Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 76Neoplasm Metastasis 13Stomach Neoplasms 12Neoplasms 8Breast Neoplasms, Male 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Endometrial Neoplasms 6Esophageal Neoplasms 5Colorectal Neoplasms 5Brain Neoplasms 5Ovarian Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Vulvar Neoplasms 2Vipoma 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Urethral Neoplasms 2Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Testicular Neoplasms 2Somatostatinoma 2Solid Tumor 2

Interventions

pembrolizumab 1folfirinox 1durvalumab 1Trastuzumab 1Single Person 1Paclitaxel 1Nivolumab 1Irinotecan 1IFL protocol 1Folfox protocol 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastroesophageal Adenocarcinoma × Trastuzumab × Clear all
NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡